Aptevo Therapeutics Inc.
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.71M | 7.75M | 8.07M | 10.25M | 16.90M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.69M | 1.64M | 798.00K | 1.13M | 1.47M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 256.00K | 624.00K | 715.00K | 691.00K | 689.00K |
| Total Current Assets | 10.66M | 10.01M | 9.58M | 12.07M | 19.07M |
|
|
|||||
| Total Current Assets | 10.66M | 10.01M | 9.58M | 12.07M | 19.07M |
| Net Property, Plant & Equipment | 4.93M | 5.13M | 5.34M | 5.56M | 5.78M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 15.59M | 15.15M | 14.92M | 17.63M | 24.84M |
|
|
|||||
| Total Accounts Payable | 3.05M | 3.53M | 3.74M | 3.72M | 3.98M |
| Total Accrued Expenses | 1.86M | 922.00K | 892.00K | 1.61M | 2.10M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 769.00K | 700.00K | 700.00K | 700.00K | -- |
| Total Finance Division Other Current Liabilities | 529.00K | 728.00K | 91.00K | 268.00K | 1.14M |
| Total Other Current Liabilities | 529.00K | 728.00K | 91.00K | 268.00K | 1.14M |
| Total Current Liabilities | 6.21M | 5.88M | 5.42M | 6.30M | 7.22M |
|
|
|||||
| Total Current Liabilities | 6.21M | 5.88M | 5.42M | 6.30M | 7.22M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.63M | 4.83M | 5.03M | 5.21M | 5.40M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 14.00K | 14.00K | 14.00K | -- |
| Total Liabilities | 10.84M | 10.73M | 10.46M | 11.53M | 12.62M |
|
|
|||||
| Common Stock & APIC | 252.33M | 245.69M | 240.63M | 236.38M | 235.67M |
| Retained Earnings | -247.58M | -241.27M | -236.16M | -230.28M | -223.45M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 4.76M | 4.42M | 4.46M | 6.10M | 12.22M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.76M | 4.42M | 4.46M | 6.10M | 12.22M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.76M | 4.42M | 4.46M | 6.10M | 12.22M |
|
|
|||||